Hardikkumar Ghelani | Sr. Scientist
Merck

Hardikkumar Ghelani, Sr. Scientist, Merck

Hardikkumar Ghelani is a Senior Scientist at Merck with a strong background in research and development within the pharmaceutical industry. With over a decade of experience, he has a proven track record of leading innovative projects and driving scientific advancements. Hardikkumar is known for his expertise in analytical chemistry, making significant contributions to the field.

Throughout his career, Hardikkumar has demonstrated a passion for pushing the boundaries of scientific knowledge and leveraging cutting-edge technologies to solve complex challenges. His work at Merck has been instrumental in the development of novel therapeutics and advancements in precision medicine. Hardikkumar's dedication to excellence and his ability to collaborate effectively with cross-functional teams have been key to his success in driving impactful results.

As a speaker at Future Labs Live USA 2025, Your Gateway to Lab Technology, Hardikkumar will share his insights on the latest trends and innovations in lab technology. His presentation will offer valuable perspectives on how advancements in technology are shaping the future of scientific research and transforming the way we approach drug discovery and development. Attendees can expect to gain valuable knowledge and practical strategies from Hardikkumar's expertise in the field.

Overall, Hardikkumar Ghelani is a respected professional in the scientific community, known for his commitment to driving progress and making a positive impact in the pharmaceutical industry. His participation at Future Labs Live USA 2025 is sure to inspire and educate attendees on the exciting possibilities that lie ahead in lab technology.

Appearances:



Day 2: 16th October @ 14:40

Automation on analytical laboratory for finished product dosage forms

The pharmaceutical industry has long aimed to fully automate analytical laboratories, from sample preparation to final data reporting. Automation enables continuous sample processing, manages complex testing procedure, increases precision and data quality, ensures traceable audit trails for compliance, eases lab transfers, reduces errors and costs, and enhances safety. Many companies now use automated platforms for tasks like dissolution, content uniformity and assay/degradation across various dosage forms. This study is expected to encourage a wider application of the very advanced automated system usage in routine pharmaceutical analysis as dissolution and assay/degrades, and support stability studies in late phase product development and commercial phase.

last published: 12/Sep/25 17:45 GMT

back to speakers

GET INVOLVED

For conference production and speaking opportunites:

ellie.whitehead@terrapinn.com 

For sponsorship and exhibition opportunities:

joe.knight@terrapinn.com